Search research articles
Contact Us
Filters
Showing results (371-380 of 373) with videos related to
Page
of 38
Sort By:
You have reached the last page of results.
This site can display upto 373 results.
The Lancet. Oncology
|
February 18, 2017
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial
Pin Zhang, Tao Sun, Qingyuan Zhang, et al.
Cancer
|
July 26, 2020
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)
Binghe Xu, Xichun Hu, Jifeng Feng, et al.
American Journal of Human Genetics
|
March 3, 2009
Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups
Dong-Hai Xiong, Xiao-Gang Liu, Yan-Fang Guo, et al.
Page
of 38
Search research articles
Search
Showing results (371-380 of 373) with videos related to
Sort By:
Page
of 38
You have reached the last page of results.
This site can display upto 373 results.
The Lancet. Oncology
|
February 18, 2017
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial
Pin Zhang, Tao Sun, Qingyuan Zhang, et al.
Cancer
|
July 26, 2020
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)
Binghe Xu, Xichun Hu, Jifeng Feng, et al.
American Journal of Human Genetics
|
March 3, 2009
Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups
Dong-Hai Xiong, Xiao-Gang Liu, Yan-Fang Guo, et al.
Page
of 38